Introduction {#Sec1}
============

The dynamic spread of carbapenemase-producing Enterobacteriaceae, *Pseudomonas* spp. and *Acinetobacter* spp. has been observed all over the world in recent years. The predominant carbapenemases include β-lactamases of the Ambler class A (KPCs), metallo-β-lactamases (MBLs) of the class B (VIMs, IMPs, NDMs) and carbapenem-hydrolysing oxacillinases of the class D (OXA-23, OXA-24/40, OXA-48 or OXA-58 types) \[[@CR1]--[@CR9]\]. Carbapenemase producers notoriously exhibit multidrug resistance phenotypes, making treatment of infections extremely difficult \[[@CR10]--[@CR13]\]. Therefore, quick, unambiguous, easy and cheap identification of carbapenemase-producing bacteria has been one of the priorities of modern clinical microbiology. The biochemical Carba NP test for Enterobacteriaceae and *Pseudomonas* spp., and its variant CarbAcineto for *Acinetobacter* spp., were proposed to address this challenge in 2012 and 2014, respectively \[[@CR1], [@CR14], [@CR15]\]. Both tests were reported to have high specificity and sensitivity for all of the major carbapenemase types \[[@CR1], [@CR14], [@CR15]\]; however, it was shown that, for some enzymes, the sensitivity relies strongly on the type of microbial medium used for bacteria cultivation \[[@CR16]--[@CR18]\]. The original Carba NP test was soon followed by modified variants, and has been commercialised \[[@CR19]--[@CR26]\].

The aim of this study was to evaluate the Carba NP and CarbAcineto tests for the detection of carbapenemase-producing Enterobacteriaceae, *Pseudomonas* spp. and *Acinetobacter* spp. cultivated on different media. Moreover, the Carba NP/CarbAcineto tests were assessed in the routine diagnostics of carbapenemase producers conducted by the National Reference Centre for Susceptibility Testing (NRCST) in Poland in 2014.

Materials and methods {#Sec2}
=====================

Assessment of the Carba NP and CarbAcineto tests: strain collection and cultivation media {#Sec3}
-----------------------------------------------------------------------------------------

For the initial evaluation of the Carba NP and CarbAcineto tests, a total of 107 strains were used: 81 carbapenemase producers that were well characterised with phenotypic methods, polymerase chain reaction (PCR) and sequencing, and 26 carbapenemase non-producers, including 21 meropenem-non-susceptible strains (Table [1](#Tab1){ref-type="table"}). Both tests were performed by the in-house protocol as previously described \[[@CR14], [@CR18]\]. The results presented are those that were recorded after 2 h of incubation time. For cultivation of bacteria, a number of non-selective or screening media and the Mueller--Hinton ready-to-use agar plates, products of six manufacturers, were used (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).Table 1Isolates used in the Carba NP/CarbAcineto tests evaluationSpecies, total numberCarbapenemase genesNo.Carbapenemase-positive, *n* = 81Enterobacteriaceae, *n* = 34  *K. pneumoniae*, *n* = 15KPC4NDM5VIM2IMP1OXA-483  *K. oxytoca*, *n* = 3NDM1VIM2  *E. coli*, *n* = 9KPC2NDM4OXA-483  *E. cloacae*, *n* = 5KPC1NDM1VIM3  *C. freundii*, *n* = 2KPC2*Pseudomonas* spp., *n* = 15  *P. aeruginosa*, *n* = 9VIM8IMP1  *P. putida*, *n* = 6VIM6*Acinetobacter* spp., *n* = 32  *A. baumannii*VIM6  *A. lwoffii*VIM7  *A. junii*VIM3  *A. baumannii*OXA-239  *A. baumannii*OXA-24/406  *A. baumannii*OXA-581Carbapenemase-negative, *n* = 26^a^  *K. pneumoniae*No10  *P. aeruginosa*No6  *Acinetobacter* spp*.*No10^a^Of the 26 carbapenemase-negative isolates, 21 isolates were carbapenem-non-susceptible (8 *K. pneumoniae*, 6 *P. aeruginosa* and 7 *Acinetobacter* spp.) Table 2The results of the Carba NP test for Enterobacteriaceae isolates (34 carbapenemase producers and 10 carbapenemase non-producers) cultivated on a set of microbial mediaMicrobiological mediaManufacturerVIM; *n* = 7^a^IMP; *n* = 1^a^NDM; *n* = 11^a^KPC; *n* = 9^a^OXA-48; *n* = 6^a^c-np^b^; *n* = 10^a^++/−−NG (NI)+NG++/−−NG (NI)+NG++/−−NG++/−−NG (NI)Columbia blood agarBD7110(1)9610chromID CPS agarbioMérieux71119610CHROMagar Orientation MediumBD71119619Brilliance UTI agarOxoid711195137Brilliance UTI Clarity agarOxoid711195137Brilliance ESBL agarOxoid6(1)110(1)931219chromID ESBL agarbioMérieux711195191Brilliance CRE agarOxoid611118121328chromID CARBA agarbioMérieux322110195173KPC CHROM agarGRASO71119512161chromID OXA-48 agarbioMérieux711109610MHBD711019627(1)MHEbioMérieux71101968(2)MHFbioMérieux1612369610MHOxoid71119513(7)MHGRASO71119616(3)MHLiofilchem71101969(1)MHBio-Rad52123696118^a^+, positive; +/−, questionable; −, negative; (NI), not interpretable; NG, no growth^b^c-np, carbapenemase-non-producers Table 3The Carba NP results for *Pseudomonas* spp. (15 carbapenemase producers and 6 carbapenemase non-producers) and the CarbAcineto results for *Acinetobacter* spp. (32 carbapenemase producers and 10 carbapenemase non-producers) grown on a set of microbiological mediaCarba NPCarbAcineto*Pseudomonas* spp.*Acinetobacter* spp.Microbiological mediaManufacturerVIM; *n* = 14^a^IMP; *n* = 1^a^c-np^b^; *n* = 6^a^VIM; *n* = 16^a^OXA-like; *n* = 16^a^c-np^b^; *n* = 10^a^++/−−NG (NI)+NG (NI)++/−−NG (NI)++/−−NG (NI)++/−−NG (NI)++/−−NG (NI)Columbia blood agarBD1416161610chromID CPS agarbioMérieux1416142169(1)CHROMagar Orientation MediumBD131124114115119Brilliance UTI agarOxoid141331241519(1)Brilliance UTI Clarity agarOxoid121(1)112314215118(1)Brilliance ESBL agarOxoid832(1)11513 (3)1321126 (1)chromID ESBL agarbioMérieux12111141141115181 (1)Brilliance CRE agarOxoid141132102415172 (1)chromID CARBA agarbioMérieux10131113110615182KPC CHROM agarGRASO12216112315182chromID OXA-48 agarbioMérieux338133196924137MHBio-Rad951151616118MHLiofilchem13111516141110MHGRASO13116161618(1)MHBD141616151127MHOxoid13116161610MHEbioMérieux1412416169(1)MHFbioMérieux53616113215118(1)^a^+, positive; +/−, questionable; −, negative; (NI), not interpretable; NG, no growth^b^c-np, carbapenemase-non-producers

The Carba NP and CarbAcineto tests in routine reference diagnostics {#Sec4}
-------------------------------------------------------------------

In the second part of this work, the Carba NP and CarbAcineto tests were implemented into the routine activity of the NRCST, which is responsible for the reference diagnostics and surveillance of carbapenemase-producing Gram-negative pathogens in Poland. Both tests were performed along with the phenylboronic acid disc test \[[@CR27]\], double-disc synergy test with EDTA (DDST-EDTA) \[[@CR28]\], temocillin disc test \[[@CR29]\] for the phenotypic detection of KPCs, MBLs and OXA-48 types, respectively \[[@CR30]\], spectrophotometric assay for imipenem hydrolysis \[[@CR31]\] and PCR for *bla* ~KPC~-, *bla* ~VIM~-, *bla* ~IMP~-, *bla* ~NDM~-, *bla* ~OXA-48~-, *bla* ~OXA-23~-, *bla* ~OXA-24/40~- and *bla* ~OXA-58~-like genes \[[@CR32]\]. This analysis was done on 1282 isolates in total (Table [4](#Tab4){ref-type="table"}), including 915 Enterobacteriaceae, 309 *Pseudomonas* spp. and 58 *Acinetobacter* spp. collected from April to the end of December 2014 in hospitals all over Poland. All these isolates were cultivated only on Columbia blood agar plates.Table 4Performance of the Carba NP/CarbAcineto tests in the analysis of 1282 surveillance isolates submitted to the National Reference Centre for Susceptibility Testing (NRCST) from April to December 2014Enterobacteriaceae (total, *n* = 915)^a^*Pseudomonas* spp. (total, *n* = 309)^a^*Acinetobacter* spp. (total, *n* = 58)^a^Carbapenemase-positive, *n* = 451Carbapenemase-positive, *n* = 118Carbapenemase-positive, *n* = 54Carba NP positive, *n* = 432Carba NP positive, *n* = 115CarbAcineto positive, *n* = 48KPC, *n* = 77VIM, *n* = 115*A. baumannii* VIM, *n* = 2  *K. pneumoniae*, *n* = 75*P. aeruginosa*, *n* = 111*A. lwoffii* VIM, *n* = 3  *E. coli*, *n* = 1*P. putida*, *n* = 4*A. junii* VIM, *n* = 3  *E. cloacae*, *n* = 1*A. baumannii* OXA-24/40-like, *n* = 30NDM, *n* = 275*A. baumannii* OXA-23-like, *n* = 10  *K. pneumoniae*, *n* = 267  *E. coli*, *n* = 2  *E. cloacae*, *n* = 4  *S. marcescens*, *n* = 2VIM, *n* = 57  *K. pneumoniae*, *n* = 12  *E. coli*, *n* = 6  *E. cloacae*, *n* = 26  *C. freundii*, *n* = 8  *S. marcescens*, *n* = 4  *K. oxytoca*, *n* = 1OXA-48, *n* = 23  *K. pneumoniae*, *n* = 7  *E. coli*, *n* = 14  *E. aerogenes*, *n* = 2Carba NP questionable, *n* = 18Carba NP questionable, *n* = 3CarbAcineto questionable, *n* = 6  *K. pneumoniae* NDM, *n* = 14*P. aeruginosa* VIM, *n* = 3*A. baumannii* OXA-24/40-like, *n* = 1  *K. pneumoniae* OXA-48, *n* = 1*A. baumannii* OXA-23-like, *n* = 3  *E. coli* OXA-48, *n* = 1*A. baumannii* OXA-58, *n* = 2  *E. cloacae* KPC, *n* = 1  *C. freundii* VIM, *n* = 1Carba NP not interpretable, *n* = 1  *K. pneumoniae* NDM, *n* = 1Carbapenemase-negative, *n* = 464Carbapenemase-negative, *n* = 191Carbapenemase-negative, *n* = 4Carba NP negative, *n* = 433Carba NP negative, *n* = 189CarbAcineto negative, *n* = 4Carba NP questionable, *n* = 30Carba NP questionable, *n* = 2  *K. pneumoniae*, *n* = 19*P. aeruginosa*, *n* = 2  *E. cloacae*, *n* = 9  *S. marcescens*, *n* = 1  *P. mirabilis, n* = 1Carba NP not interpretable, *n* = 1  *K. pneumoniae*, *n* = 1Sensitivity 95.8%\
(95% CI, 93.9--97.6%)Sensitivity 97.5%\
(95% CI, 94.6--100%)Sensitivity 88.9%\
(95% CI, 80.4--97.4%)Specificity 93.3%\
(95% CI, 90.9--95.6%)Specificity 99.0%\
(95% CI, 97.6--100%)PPV 95.8%\
(95% CI, 93.9--97.6%)PPV 97.5%\
(95% CI, 94.6--100%)PPV 88.9%\
(95% CI, 80.4--97.4%)NPV 93.3%\
(95% CI, 90.9--95.6%)NPV 99.0%\
(95% CI, 97.6--100%)^a^PPV, positive predictive value; NPV, negative predictive value; CI, confidence interval

Results {#Sec5}
=======

Assessment of the Carba NP and CarbAcineto tests and the cultivation media {#Sec6}
--------------------------------------------------------------------------

For Enterobacteriaceae, the Carba NP test performed well, with the carbapenemase-producing strains cultured on most of the non-selective or screening media (Table [2](#Tab2){ref-type="table"}). False-negative results were obtained only for single isolates with VIMs or OXA-48s grown on three types of chromogenic media. When bacteria were cultivated on Mueller--Hinton (MH) agars, the Carba NP test was positive for all KPC, IMP and all but one OXA-48 producers, while false-negative or questionable results were obtained for NDM- and VIM-producing strains. For a number of carbapenemase-negative strains picked up from some media, the results were questionable and for single strains were false-positive.

The results of the Carba NP test for *Pseudomonas* spp. strains are presented in Table [3](#Tab3){ref-type="table"}. In the case of carbapenemase (VIM or IMP) producers, the best results were observed for the strains cultivated on the Columbia blood agar, chromID CPS, Brilliance UTI agar (Oxoid) and Brilliance CRE agar (Oxoid). The false-negative results were observed for some isolates cultivated on five other chromogenic media, and on MH (Oxoid) and MHF (bioMérieux) agars. For single carbapenemase-negative strains cultivated on five media, false-positive results were observed.

The results of the CarbAcineto test for *Acinetobacter* spp. strains are shown in Table [3](#Tab3){ref-type="table"}. As in the case of Enterobacteriaceae and *Pseudomonas* spp., the impact of the cultivation medium on CarbAcineto was revealed; moreover, for isolates with OXA-like carbapenemases, the correct results were observed more often than for VIM-positive strains (Table [3](#Tab3){ref-type="table"}).

The Carba NP and CarbAcineto tests in routine reference diagnostics {#Sec7}
-------------------------------------------------------------------

The results of the comparison of the Carba NP/CarbAcineto tests with the standard methodology used by the NRCST, obtained with 1282 bacterial isolates suspected of carbapenemase production, are presented in Table [4](#Tab4){ref-type="table"}. The phenotypic tests and PCRs detected various carbapenemases in 451/915 Enterobacteriaceae, 118/309 *Pseudomonas* spp. and 54/58 *Acinetobacter* spp. isolates. For Enterobacteriaceae, the overall sensitivity and positive predictive value (PPV) of Carba NP were 95.8% \[95% confidence interval (CI), 93.9--97.6%\], and the specificity and negative predictive value (NPV) were 93.3% (95% CI, 90.9--95.6%). For *Pseudomonas* spp. the sensitivity and PPV were 97.5% (95% CI, 94.6--100%), and the specificity and NPV were 99.0% (95% CI, 97.6--100%). For *Acinetobacter* spp., the sensitivity and PPV of CarbAcineto were 88.9% (95% CI, 80.4--97.4%).

Discussion {#Sec8}
==========

The Carba NP test was described for the first time in 2012 by Nordmann et al. as a rapid, easy and cheap method for carbapenemase detection in Enterobacteriaceae and *Pseudomonas* spp., with high sensitivity and specificity \[[@CR1], [@CR15]\]. In previous studies, the test was evaluated by several groups, often confirming the original observations \[[@CR2], [@CR19], [@CR33]--[@CR35]\]. However, one study undermined the sensitivity in the case of MBL-producing strains \[[@CR2]\]. The problem turned out to be associated with the cultivation medium used \[[@CR16]--[@CR18]\], and the follow-up study by Dortet et al. documented well the impact of microbiological media on the performance of Carba NP \[[@CR18]\].

In the first part of this work, well-characterised Enterobacteriaceae, *Pseudomonas* spp. and *Acinetobacter* spp. strains with various carbapenemases were used, along with a broad panel of commercially available media. The results clearly illustrated the influence of the media on the Carba NP/CarbAcineto results. According to our experience, the Columbia blood agar is the best choice for the cultivation of bacteria for the Carba NP/CarbAcineto tests, providing the highest sensitivity and clarity of the results. The VIM or NDM producers harvested from most of the MH agars yielded a remarkable number of false-negative results, which were most probably related to lower zinc ions' concentrations that is crucial for the MBL activity \[[@CR18]\]. Owing to the low incidence of OXA-48 producers in Poland so far, only six such isolates were used in this work, and all of these were clearly positive in Carba NP, in contrast to some other reports \[[@CR17], [@CR25], [@CR34]--[@CR37]\]. This study has definitely confirmed the usefulness of the CarbAcineto test for the detection of the acquired carbapenemases in *Acinetobacter* spp. \[[@CR8], [@CR38], [@CR39]\] and for distinguishing such isolates from hyperproducers of the natural OXA-51 types and from the carbapenemase-negative carbapenem-non-susceptible isolates, which is important for epidemiological reasons.

The Carba NP and CarbAcineto tests have been used in the NRCST from the end of 2013 and March 2014, respectively, and now are included in its routine algorithm for carbapenemase detection as reliable, inexpensive and easy screening tests, reducing remarkably the time for the first feedback information for clinical laboratories. Based on own experience, and in the context of the alarming spread of carbapenemase-producing Gram-negative pathogens in Poland, the NRCST has been recommending Carba NP/CarbAcineto tests for use in diagnostic microbiology laboratories all over the country.
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